RSSCategory: New Digital Imaging Technologies

Fimmic Launches Aiforia™ Cloud, Bringing Self-Service Deep Learning AI to Digital Pathology

| March 16, 2018 | 0 Comments

 Aiforia will be introduced at the USCAP Annual Meeting in Vancouver, March 18-21, 2018, booth #833 Fimmic, a forerunner in developing cloud-based, intelligent image analysis solutions to Digital Pathology, announces the launch of its new Aiforia™ Cloud. Aiforia, formerly known as WebMicroscope®, brings together its established deep learning artificial intelligence (AI) image analysis cloud solution with […]

Continue Reading

Proscia Inks Agreement to Bring Deep-Learning Technology to Dermatopathology

| March 15, 2018 | 0 Comments

Landmark agreement positions Proscia to transform dermatopathology market − and opens doors to additional lab partnerships PHILADELPHIA — Proscia Inc., creators of AI-powered digital pathology software, today announced it has signed a first-of-its-kind agreement with one of the largest dermatopathology labs in the country, signaling Proscia’s entrance into the dermatopathology market and ushering in a new […]

Continue Reading

3DHISTECH Luncheon Symposium: “Digital Pathology Today” at the USCAP 2018

| March 14, 2018 | 0 Comments

Join us to welcome guest speakers from the UK, the Netherlands and Hungary sharing their experience using whole-slide imaging in clinical pathology. When: 12 noon on Wednesday, March 21, 2018 Where: at the VCC West Meeting Room 203 (at the Vancouver Convention Centre) Also, visit us at our booth #532 right in the center of the […]

Continue Reading

OptraSCAN Launches Third Generation On-Demand Digital Pathology® System at USCAP 2018

| March 14, 2018 | 0 Comments

Reduced scan times and competitive prices with digital microscopes, now make Digital Pathology more appealing to mainstream marketplace OptraSCAN will be at exhibiting at USCAP in Vancouver, March 17-23 at booth #722 SUNNYVALE, CA — OptraSCAN today announced its third generation On-Demand Digital Pathology® system for researchers and clinicians. The third generation OptraSCAN® brightfield scanner […]

Continue Reading

Special Book Discount! Tissue Phenomics: Profiling Cancer Patients for Treatment Decisions

| March 13, 2018 | 0 Comments

Just announced, we would like to offer an exclusive 20% discount to Tissue Pathology readers, which would include free international shipping as well! Use this Tissue Pathology reader link to order the Tissue Phenomics book and use this special code at checkout: “PAN01” For more information on the book, please visit Just another perk to reading […]

Continue Reading

Windstream Enterprise to Discuss Preparing IT infrastructure for Digital Pathology at HIMSS18

| March 7, 2018 | 1 Comment

Interesting news at HIMSS Annual Meeting. A leading provider of advanced network communications and technology solutions presented recently presented on network requirements for digital pathology. If any readers attended this session would appreciate hearing about the discussion.  Session will explore challenges and solutions for managing data elements up to 60 times larger than digitized radiology images […]

Continue Reading

Israeli AI Cancer Startup Lands $5 Million

| March 7, 2018 | 0 Comments

In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help pathologists in the job. Tel Aviv-based Nucleai Ltd. announced on Monday it completed a $5 […]

Continue Reading

New Webinar: Deep Learning to Guide Molecular pathology – What This Means For Your Lab?

| March 6, 2018 | 0 Comments

March 13, 2018 at 4pm GMT Register for this webinar: Click here Cancer care has evolved over time to precise, targeted & personalized therapy options. This evolution is primarily fueled by molecular pathology, which is now under pressure from increasing tests and a shortage of pathologists. Join Prof. Manuel Salto-Tellez, Queens University Belfast & Dr. Peter […]

Continue Reading

AI Can Diagnose Heart Disease and Lung Cancer More Accurately Than Doctors

| February 25, 2018 | 0 Comments

A pair of recently developed AI systems can diagnose lung cancer and heart disease more accurately than human doctors. These AIs have the potential to save billions of dollars and countless lives if widely adopted. Improved Diagnosis Artificial intelligence (AI) has already proven useful in the healthcare industry, and now, two newly developed AI diagnostics systems […]

Continue Reading

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

Mass Validation Study of OptraSCAN Digital Pathology Leads to Approval by Government of India

| February 7, 2018 | 0 Comments

Largest digital pathology study to date, analyzing and validating over 6600 FFPE slides, yields an approval for the use of OptraSCAN® whole slide scanners in India medical settings SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN today announced it has successfully completed the mass validation of its whole slide digital scanner OptraSCAN® with the support of India’s Biotechnology Industry Research […]

Continue Reading

Digital Pathology Extending Through UK as OptraSCAN Welcomes First On-Demand UK Customer

| January 24, 2018 | 0 Comments

NHS Trust Plymouth Hospitals, Derriford Hospital, implements On-Demand Digital Pathology® for research and training, as the adoption of digital pathology workflows increases OptraSCAN today announced its first UK-based customer NHS Trust Plymouth Hospital, Derriford. Derriford Hospital plans to utilize digital pathology for routine research and training of professionals in the field of pathology and digital […]

Continue Reading

HalioDx closed a Series B round of €18.5 million (US$22.3 million)

| January 17, 2018 | 0 Comments

This funding will accelerate the development of Immunoscore® in selected cancers, and support set up of commercial activities in the US This round was led by PSIM fund managed by Bpifrance in the framework of the program ‘Investing for the Future’ Marseille, France, January 17, 2018 – HalioDx, a diagnostic company expert in the analysis […]

Continue Reading

Flagship Biosciences ActionAssays Deliver Actionable Data to Drive Immuno-Oncology Decisions

| January 16, 2018 | 0 Comments

Flagship Biosciences has introduced a new menu of services to help drug developers more confidently define their path to success. ActionAssays is a comprehensive catalog of brightfield immunohistochemistry (IHC) assays that provide actionable data to define and advance biomarker programs. Flagship Biosciences has introduced a new menu of services to help drug developers more confidently […]

Continue Reading